Blanchet O - Search Results

1

A Metabolomic Profile of Seminal Fluid in Extremely Severe Oligozoopermia Suggesting an Epididymal Involvement.

Serri O, Boguenet M, Chao de la Barca JM, Bouet PE, El Hachem H, Blanchet O, Reynier P, May-Panloup P. Serri O, et al. Among authors: blanchet o. Metabolites. 2022 Dec 15;12(12):1266. doi: 10.3390/metabo12121266. Metabolites. 2022. PMID: 36557304 Free PMC article.

2

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks.

Deneberg S, Guardiola P, Lennartsson A, Qu Y, Gaidzik V, Blanchet O, Karimi M, Bengtzén S, Nahi H, Uggla B, Tidefelt U, Höglund M, Paul C, Ekwall K, Döhner K, Lehmann S. Deneberg S, et al. Among authors: blanchet o. Blood. 2011 Nov 17;118(20):5573-82. doi: 10.1182/blood-2011-01-332353. Epub 2011 Sep 29. Blood. 2011. PMID: 21960591 Free article.

3

Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study.

Guièze R, Cornillet-Lefebvre P, Lioure B, Blanchet O, Pigneux A, Recher C, Bonmati C, Fegueux N, Bulabois CE, Bouscary D, Vey N, Delain M, Turlure P, Himberlin C, Harousseau JL, Dreyfus F, Béné MC, Ifrah N, Chevallier P; GOELAMS. Guièze R, et al. Among authors: blanchet o. Am J Hematol. 2012 Dec;87(12):1052-6. doi: 10.1002/ajh.23311. Epub 2012 Aug 22. Am J Hematol. 2012. PMID: 22911473 Free article. Clinical Trial.

4

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients.

Tamburini J, Elie C, Bardet V, Chapuis N, Park S, Broët P, Cornillet-Lefebvre P, Lioure B, Ugo V, Blanchet O, Ifrah N, Witz F, Dreyfus F, Mayeux P, Lacombe C, Bouscary D. Tamburini J, et al. Among authors: blanchet o. Blood. 2007 Aug 1;110(3):1025-8. doi: 10.1182/blood-2006-12-061283. Epub 2007 Apr 10. Blood. 2007. PMID: 17426258 Free article. Clinical Trial.

5

Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expression.

Blanchet O, Bourge JF, Zinszner H, Israel A, Kourilsky P, Dausset J, Degos L, Paul P. Blanchet O, et al. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3488-92. doi: 10.1073/pnas.89.8.3488. Proc Natl Acad Sci U S A. 1992. PMID: 1565643 Free PMC article.

6

Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition.

Zandecki M, Laï JL, Geneviève F, Bernardi F, Volle-Rémy H, Blanchet O, François M, Cosson A, Bauters F, Facon T. Zandecki M, et al. Among authors: blanchet o. Blood. 1997 Nov 1;90(9):3682-90. Blood. 1997. PMID: 9345053 Free article.

7

Multiple nuclear factors bind to novel positive and negative regulatory elements upstream of the human MHC class I gene HLA-A11.

Blanchet O, Gazin C, L'Haridon M, Tatari Z, Degos L, Sigaux F, Paul P. Blanchet O, et al. Int Immunol. 1994 Oct;6(10):1485-96. doi: 10.1093/intimm/6.10.1485. Int Immunol. 1994. PMID: 7826940

8

Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay.

Veal N, Payan C, Fray D, Sarol L, Blanchet O, Kouyoumdjian S, Lunel F. Veal N, et al. Among authors: blanchet o. J Clin Microbiol. 1996 Dec;34(12):3097-100. doi: 10.1128/jcm.34.12.3097-3100.1996. J Clin Microbiol. 1996. PMID: 8940454 Free PMC article.

9

Dasatinib in high-risk core binding factor acute myeloid leukemia in first complete remission: a French Acute Myeloid Leukemia Intergroup trial.

Boissel N, Renneville A, Leguay T, Lefebvre PC, Recher C, Lecerf T, Delabesse E, Berthon C, Blanchet O, Prebet T, Pautas C, Chevallier P, Leprêtre S, Girault S, Bonmati C, Guièze R, Himberlin C, Randriamalala E, Preudhomme C, Jourdan E, Dombret H, Ifrah N. Boissel N, et al. Among authors: blanchet o. Haematologica. 2015 Jun;100(6):780-5. doi: 10.3324/haematol.2014.114884. Epub 2015 Feb 24. Haematologica. 2015. PMID: 25715404 Free PMC article. Clinical Trial.

10

Deregulated expression of the TAL1 gene by t(1;5)(p32;31) in patient with T-cell acute lymphoblastic leukemia.

François S, Delabesse E, Baranger L, Dautel M, Foussard C, Boasson M, Blanchet O, Bernard O, Macintyre EA, Ifrah N. François S, et al. Among authors: blanchet o. Genes Chromosomes Cancer. 1998 Sep;23(1):36-43. doi: 10.1002/(sici)1098-2264(199809)23:1<36::aid-gcc6>3.0.co;2-7. Genes Chromosomes Cancer. 1998. PMID: 9713995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page